Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Drotrecogin alfa (activated)

EU orphan designation number: EU/3/08/565   
Active ingredient: Drotrecogin alfa (activated)
Indication: Treatment of acute respiratory distress syndrome
Sponsor: Drugrecure Aps
c/o Serendex ApS, Cobis Building, Ole Maaløes vej 3, DK-2200 København, Danmark

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
27/10/2008 Centralised Orphan - Designation EMEA/OD/099/06 (2008)5449 of 22/09/2008
18/11/2008 Other procedure EMEA/OD/099/06
17/02/2010 Other procedure EMEA/OD/099/06